IDEXX Laboratories has named Michael Erickson as its next CEO, with the transition scheduled for May 2026. The company also ...

Idexx stock fell Monday despite beating fourth-quarter expectations and issuing strong guidance for 2026.

IDXX tops Q4 EPS and revenue estimates as margins expand. However, shares dip during the pre-market trading, while 2026 ...

Feb 2 (Reuters) - Animal diagnostics maker IDEXX Laboratories on Monday forecast 2026 revenue and profit above Wall Street estimates, betting that resilient demand at veterinary clinics and higher ...

IDEXX Laboratories Inc. (NASDAQ: IDXX) reported better-than-expected fourth-quarter financial results and issued a fiscal 2026 forecast on Monday.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2025 Earnings Call Transcript February 2, 2026 IDEXX Laboratories, Inc. beats ...

IDEXX beat earnings and revenue estimates, boosted by strong pet diagnostics growth, and forecast solid 2026 results as new ...

Q4 2025 earnings call highlights: 2026 guidance, CAG Diagnostics growth, inVue Dx/Cancer Dx momentum, margins & risks—read now.

Check out the companies making headlines in midday trading. Palantir Technologies — Shares of the data analytics company were ...

Ahead of Q4 earnings, IDXX eyes double-digit revenue and EPS growth, driven by CAG momentum, new diagnostics and steady Water ...

A new diagnostic imaging solution with a lower radiation dose than earlier iterations was launched at the 2026 Veterinary Meeting & Expo (VMX) in Orlando, Florida, by IDEXX. The ImageVue DR50 Plus ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...